July 23, 2014
Prevacus

Photo:

Jacob VanLandingham

Profile

Prevacus

| 2/22/2013

Neuroscientist Jacob VanLandingham, an assistant professor at Florida State University's college of medicine, began research in 2004 to develop a drug to treat concussions. "We recognized within the last few years between military and sports injuries, that concussions have become an epidemic, so we made an effort to find something for this population." The result: VanLandingham recently patented a neurosteroid drug and launched a company, Prevacus, at Tallahassee’s Innovation Park, for work on funding, preclinical trials and product refinement. The development has sparked interest from the Department of Defense and from the University of Pittsburgh Medical Center, a professional sports affiliate that has agreed to help with clinical trials, which could begin within the next 18 to 36 months.

Tags: Trendsetters, Healthcare, Research & Development

Digital Access

DIRECT DIGITAL ACCESS
Add digital to your current subscription, purchase a single ditgital issue, or start a new subscription to Florida Trend.

TABLE OF CONTENTS
An overview of the features and articles in this month's issue of Florida Trend.

ACCESS THIS ISSUE »

Florida Business News

Florida Trend Video Pick

Greenlight Pinellas: Connecting Tampa Bay
Greenlight Pinellas: Connecting Tampa Bay

Chris Steinocher, President & CEO, St. Petersburg Area Chamber of Commerce, explains the benefits of a proposed public mass transit system with plans to unite the Tampa Bay Area.

Earlier Videos | Viewpoints@FloridaTrend

Ballot Box

Do you agree with the Florida jury who just awarded $23 billion to the wife of a (deceased) smoker in her suit against RJ Reynolds?

  • Yes, justice has been served
  • No, that is too much

See Results

Ballot Box
Subscribe